These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 7633105)

  • 1. MR imaging of myositis ossificans: variable patterns at different stages.
    Shirkhoda A; Armin AR; Bis KG; Makris J; Irwin RB; Shetty AN
    J Magn Reson Imaging; 1995; 5(3):287-92. PubMed ID: 7633105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Magnetic resonance imaging of myositis ossificans: analysis of seven cases.
    De Smet AA; Norris MA; Fisher DR
    Skeletal Radiol; 1992; 21(8):503-7. PubMed ID: 1465642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myositis ossificans: MR appearance with radiologic-pathologic correlation.
    Kransdorf MJ; Meis JM; Jelinek JS
    AJR Am J Roentgenol; 1991 Dec; 157(6):1243-8. PubMed ID: 1950874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of pseudocapsule of renal cell carcinoma with MR imaging and CT.
    Yamashita Y; Honda S; Nishiharu T; Urata J; Takahashi M
    AJR Am J Roentgenol; 1996 May; 166(5):1151-5. PubMed ID: 8615260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of hepatocellular carcinoma with percutaneous ethanol injection: evaluation with contrast-enhanced MR imaging.
    Bartolozzi C; Lencioni R; Caramella D; Mazzeo S; Ciancia EM
    AJR Am J Roentgenol; 1994 Apr; 162(4):827-31. PubMed ID: 8141000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of fat-suppression technique and gadopentetate dimeglumine in magnetic resonance imaging evaluation of intraocular tumors and simulating lesions.
    De Potter P; Flanders AE; Shields JA; Shields CL; Gonzales CF; Rao VM
    Arch Ophthalmol; 1994 Mar; 112(3):340-8. PubMed ID: 8129659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimizing brain MR imaging protocols with gadopentetate dimeglumine: enhancement of intracranial lesions on spin-density- and T2-weighted images.
    Wessbecher FW; Maravilla KR; Dalley RW
    AJNR Am J Neuroradiol; 1991; 12(4):675-9. PubMed ID: 1882743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gadolinium-enhanced T1-weighted versus T2-weighted imaging of scrotal disorders: is there an indication for MR imaging?
    Müller-Leisse C; Bohndorf K; Stargardt A; Sohn M; Neuerburg J; Adam G; Wein B; Urhahn R; Günther RW
    J Magn Reson Imaging; 1994; 4(3):389-95. PubMed ID: 8061438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic value of gadopentetate dimeglumine for 1.5-T MR imaging of musculoskeletal masses: comparison with unenhanced T1- and T2-weighted imaging.
    Rosenthal RE; Wozney P
    J Magn Reson Imaging; 1991; 1(5):547-51. PubMed ID: 1790379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spinal epidural abscess: evaluation with contrast-enhanced MR imaging.
    Sandhu FS; Dillon WP
    AJNR Am J Neuroradiol; 1991; 12(6):1087-93. PubMed ID: 1763732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MR imaging of peritoneal disease: comparison of contrast-enhanced fast multiplanar spoiled gradient-recalled and spin-echo imaging.
    Low RN; Sigeti JS
    AJR Am J Roentgenol; 1994 Nov; 163(5):1131-40. PubMed ID: 7976889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fast multiplanar spoiled gradient-recalled imaging of the liver: pulse sequence optimization and comparison with spin-echo MR imaging.
    Low RN; Francis IR; Herfkens RJ; Jeffrey RB; Glazer GM; Foo TK; Shimakawa A; Pelc NJ
    AJR Am J Roentgenol; 1993 Mar; 160(3):501-9. PubMed ID: 8381572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MR imaging of the normal and abnormal clivus.
    Kimura F; Kim KS; Friedman H; Russell EJ; Breit R
    AJR Am J Roentgenol; 1990 Dec; 155(6):1285-91. PubMed ID: 2122682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MRI Findings of Early Myositis Ossificans without Calcification or Ossification.
    Wang H; Nie P; Li Y; Hou F; Dong C; Huang Y; Hao D
    Biomed Res Int; 2018; 2018():4186324. PubMed ID: 30255094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic abscesses: MR imaging findings.
    Méndez RJ; Schiebler ML; Outwater EK; Kressel HY
    Radiology; 1994 Feb; 190(2):431-6. PubMed ID: 8284394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MR imaging of soft-tissue masses: role of gadopentetate dimeglumine.
    Benedikt RA; Jelinek JS; Kransdorf MJ; Moser RP; Berrey BH
    J Magn Reson Imaging; 1994; 4(3):485-90. PubMed ID: 8061453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breast neoplasms: T2* susceptibility-contrast, first-pass perfusion MR imaging.
    Kuhl CK; Bieling H; Gieseke J; Ebel T; Mielcarek P; Far F; Folkers P; Elevelt A; Schild HH
    Radiology; 1997 Jan; 202(1):87-95. PubMed ID: 8988196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peripheral washout: a sign of malignancy on dynamic gadolinium-enhanced MR images of focal liver lesions.
    Mahfouz AE; Hamm B; Wolf KJ
    Radiology; 1994 Jan; 190(1):49-52. PubMed ID: 8259426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rathke cleft cysts: correlation of enhanced MR and surgical findings.
    Sumida M; Uozumi T; Mukada K; Arita K; Kurisu K; Eguchi K
    AJNR Am J Neuroradiol; 1994 Mar; 15(3):525-32. PubMed ID: 8197952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MR imaging of the gastrointestinal tract with i.v., gadolinium and diluted barium oral contrast media compared with unenhanced MR imaging and CT.
    Low RN; Francis IR
    AJR Am J Roentgenol; 1997 Oct; 169(4):1051-9. PubMed ID: 9308464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.